Alta Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Alta Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,069	Closed	-$53.1K	–	132
2023 Q3	$53.1K	Hold	2,069	–	–	0.03%	128
2023 Q2	$35.7K	Hold	2,069	–	–	0.02%	133
2023 Q1	$25.1K	Hold	2,069	–	–	0.02%	136
2022 Q4	$73.8K	Hold	2,069	–	–	0.05%	141
2022 Q3	$70K	Hold	2,069	–	–	0.05%	135
2022 Q2	$76K	Hold	2,069	–	–	0.05%	136
2022 Q1	$317K	Hold	2,069	–	–	0.19%	124
2021 Q4	$611K	Hold	2,069	–	–	0.38%	86
2021 Q3	$574K	Hold	2,069	–	–	0.42%	84
2021 Q2	$567K	Buy	+2,069	New	+$741K	0.42%	89

Other funds holding PRAX

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Alta Wealth Advisors's PRAX Position: Q4 2023 in Review

Alta Wealth Advisors sold out of Praxis Precision Medicines (PRAX) in Q4 2023, closing a stake of 2,069 shares — an estimated $53.1K sold.

Alta Wealth Advisors first reported a position in PRAX in Q2 2021 and held it in 10 quarters. The position peaked at $611K in Q4 2021. 60 funds tracked by Wall St. Rank hold PRAX as of Q4 2023.

Alta Wealth Advisors reported no remaining Praxis Precision Medicines position as of Q4 2023 after selling out during the quarter.
Alta Wealth Advisors sold 2,069 Praxis Precision Medicines shares in Q4 2023, an estimated $53.1K.
Alta Wealth Advisors first reported a position in Praxis Precision Medicines in Q2 2021 and held it in 10 quarters.
Alta Wealth Advisors's Praxis Precision Medicines position peaked at $611K in Q4 2021.
60 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2023.

Based on Alta Wealth Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.